Real-world testing practices, treatment patterns, and outcomes of tyrosine kinase inhibitors (TKIs) in epidermal growth factor receptor-mutated advanced/metastatic non-small cell lung cancer: An international study.

Abstract excerpt

OBJECTIVES: To describe epidermal growth factor receptor (EGFR) mutation (EGFRm) testing practices and treatment patterns in EGFRm-positive patients with advanced/metastatic non-small cell lung cancer (NSCLC) and evaluate clinical outcomes. METHODS: Data were drawn from a cross-sectional, retrospective chart review of adult patients with advanced/metastatic NSCLC in Argentina, Belgium, Brazil, India, the...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Aged
• Share to Carcinoma, Non-Small-Cell Lung